Evidence map›Paper›PMID 31965999›Full record

ReviewJournal of biosciences2020

TET methylcytosine oxidases: new insights from a decade of research.

Chan-Wang J Lio, Xiaojing Yue, Isaac F Lopez-Moyado, Mamta Tahiliani, L Aravind, Anjana Rao

Open access · greenAbstract readReview
In one paragraph

Review in Journal of biosciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 73 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. SCoTCH-seq reveals that 5-hydroxymethylcytosine encodes regulatory information across DNA strands.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  7. Article
  8. Article
  9. TET3-overexpressing macrophages promote endometriosis.The Journal of clinical investigation · 2024
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. DNA Methylation Machinery in Gastropod Mollusks.Life (Basel, Switzerland) · 2024
    Review
  15. Article
  16. Micronutrient regulation of the DNA methylome.Frontiers in epigenetics and epigenomics · 2024
    Review
  17. Article
  18. Article
  19. Development of Novel Epigenetic Anti-Cancer Therapy Targeting TET Proteins.International journal of molecular sciences · 2023
    Article
  20. TET3-mediated DNA oxidation is essential for intestinal epithelial cell response to stressors.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 1 country.

Chan-Wang J LioDivision of Signaling and Gene Expression, La Jolla Institute for Immunology, La Jolla, CA 92037, USA.
Xiaojing Yue
Isaac F Lopez-Moyado
Mamta Tahiliani
L Aravind
Anjana Rao
La Jolla Institute for Immunology · USNational Institutes of Health · USNew York University · USSanford Consortium for Regenerative Medicine · USUniversity of California, San Diego · US

Funding

Evolutionary Analysis and Comparative Genomics of Protein SuperfamiliesZIALM594244 · NLM · NATIONAL LIBRARY OF MEDICINE · PI ARAVIND, L · 2009 to 2025
$20.3M
The TET-DNMT-ASXL1-OGT axis: relevance to clonal hematopoiesis, heterochromatin integrity and cancerR35CA210043 · NCI · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI Anjana Rao · 2016 to 2026
$10.6M
Investigating the role of TET deficiency in promoting T cell expansion and inflammationR01AI128589 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI RAO, ANJANA · 2017 to 2025
$5.3M
Illumina HiSeq 2500 Sequencing SystemS10OD016262 · OD · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI RAO, ANJANA · 2013 to 2013
$600k
FACSAria II Cell SorterS10RR027366 · NCRR · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI CROFT, MICHAEL · 2011 to 2011
$514k
NCI NIH HHS R35 CA210043NCRR NIH HHS S10 RR027366NIAID NIH HHS R01 AI128589NIH HHS S10 OD016262
6 · The paper itself

Abstract

In mammals, DNA methyltransferases transfer a methyl group from S-adenosylmethionine to the 5 position of cytosine in DNA. The product of this reaction, 5-methylcytosine (5mC), has many roles, particularly in suppressing transposable and repeat elements in DNA. Moreover, in many cellular systems, cell lineage specification is accompanied by DNA demethylation at the promoters of genes expressed at high levels in the differentiated cells. However, since direct cleavage of the C-C bond connecting the methyl group to the 5 position of cytosine is thermodynamically disfavoured, the question of whether DNA methylation was reversible remained unclear for many decades. This puzzle was solved by our discovery of the TET (Ten- Eleven Translocation) family of 5-methylcytosine oxidases, which use reduced iron, molecular oxygen and the tricarboxylic acid cycle metabolite 2-oxoglutarate (also known as a-ketoglutarate) to oxidise the methyl group of 5mC to 5-hydroxymethylcytosine (5hmC) and beyond. TET-generated oxidised methylcytosines are intermediates in at least two pathways of DNA demethylation, which differ in their dependence on DNA replication. In the decade since their discovery, TET enzymes have been shown to have important roles in embryonic development, cell lineage specification, neuronal function and cancer. We review these findings and discuss their implications here.

Indexed as

5-MethylcytosineAnimalsCell DifferentiationCell LineageCytosineDioxygenasesDNA-Binding ProteinsDNA (Cytosine-5-)-Methyltransferase 1DNA MethylationDNA ReplicationEmbryonic DevelopmentHumansOxidation-ReductionS-Adenosylmethionine5-MethylcytosineCytosineDioxygenasesDNA-Binding ProteinsDNA (Cytosine-5-)-Methyltransferase 1Dnmt1 protein, mouseS-AdenosylmethionineTET3 protein, human

Identifiers

PMID31965999
PMCPMC7216820
OpenAlexW3005323279

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.